Walking on ‘Thin’ Ice: DHC Domestically Injuncts Reddy’s from Selling Novo Nordisk’s Weightloss Drug
[A big thanks to Praharsh and Swaraj for their inputs on this post.] [Disclaimer: Long post ahead] A recent order (pdf) by the Delhi High Court (DHC) has drawn significant attention regarding the manufacture and availability of the diabetes management and weight-loss assistance drug semaglutide (sold as Wegovy and Ozempic). On 29 May 2025, the Single Bench (SB) comprising Justice Amit Bansal restrained Indian companies Dr. Reddy’s Laboratories (DRL) and OneSource Specialty Pharma Ltd (OSSPL) from selling semaglutide domestically in a […]









